Skip to content

Topical Palm Tocotrienols on Skin Biophysical Properties

A Randomised Double-blinded Placebo Controlled Study on the Effect of Topical Palm Tocotrienol on Skin Biophysical Properties

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05787743
Enrollment
41
Registered
2023-03-28
Start date
2023-07-17
Completion date
2023-11-16
Last updated
2023-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wrinkle

Keywords

tocotrienol, wrinkle, skin, topical, biophysical properties

Brief summary

A single-center, double-blind, randomised, placebo-controlled parallel-group study. Selected subjects will be randomised into active and control groups in a ratio of 1:1. Investigational products assigned will be applied on the facial skin as part of daily skin care routine. The effects will be observed during the 24-weeks of use.

Interventions

OTHERFacial cream with 2% palm tocotrienols extract

Apply on the face twice a day

Apply on the face twice a day

Sponsors

Malaysia Palm Oil Board
CollaboratorOTHER_GOV
Avantsar Sdn. Bhd.
CollaboratorUNKNOWN
Universiti Sains Malaysia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

1. Healthy female individuals, aged 25 - 45 years old, inclusive 2. Fitzpatrick skin type II to IV 3. In generally good health and skin condition as determined by the PI or designee, based on medical history reported by the subject. 4. Willing to provide informed consent and comply with study procedures

Exclusion criteria

1. Has a history of chronic drug or alcohol abuse 2. Is current smoker 3. History of severe allergic reactions to topical products or vitamin E 4. Participant with severe and uncontrolled comorbidities (including but not limited to e.g. diabetes, hypertension, kidney failure) 5. Pregnant, breastfeeding, or planning pregnancy 6. Participant with known skin conditions (including but not limited to e.g. sensitive skin, eczema and diseased skin e.g. contact dermatitis), uncontrolled medical conditions, or any other condition that could interfere with the study evaluations or increase risk to the participant 7. Participant with compromised/broken skin, tattoos, scarring, excessive hair growth, very uneven skin tone, or other conditions that would interfere with evaluations or increase risk 8. Participation in another study within 4 weeks of screening visit

Design outcomes

Primary

MeasureTime frameDescription
Percent change from baseline in wrinkle (SEw)24 weekWrinkle

Secondary

MeasureTime frameDescription
Percent change from baseline in roughness (SEr), scaliness(SEsc), smoothness (SEsm), TEWL, Young's modulus, viscoelasticity, retraction time, collagen content, skin thickness, pigmentation index, erythema index, skin colour, pH, sebum and hydration24 weekSkin biophysical properties
Percent change from baseline for Lemperle Wrinkle Assessment Scale24 weekWrinkle (scale 1 - 5; higher score for more wrinkles)
Percent change from baseline in scores of survey (BeautyQoL)24 weekSurvey (score 0 - 100%)

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026